| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
2005-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2013-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101276754-B1 |
| titleOfInvention |
Insulin-oligomeric conjugates, formulations and uses thereof |
| abstract |
The present invention provides a complex comprising a cation and an insulin compound conjugate. The insulin compound conjugate includes an insulin compound, such as human insulin or an analog thereof, conjugated to a modified moiety such as a polyethylene glycol moiety. The invention also includes solid and pharmaceutical compositions comprising the complex, methods of making the complex, and methods of using the complex in the treatment of insulin compound deficiency and other diseases. Moreover, the present invention includes novel insulin compound conjugates and modified moieties for utilizing the new insulin compound conjugates. The invention also provides fatty acid compositions for the administration of pharmaceutical agents such as novel insulin compound conjugates, and / or cation-insulin compound conjugate complexes of the invention. |
| priorityDate |
2004-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |